Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros

Banco de datos
Tipo del documento
Intervalo de año de publicación
1.
J Neuroophthalmol ; 29(3): 208-13, 2009 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-19726943

RESUMEN

BACKGROUND: Selective amygdalohippocampectomy (SelAH) is increasingly performed in patients with mesial temporal lobe epilepsy and hippocampal sclerosis. To determine whether visual field defects are less pronounced after SelAH than after standard temporal lobectomy (StTL), we retrospectively analyzed postoperative quantitative visual fields after the 2 procedures. METHODS: Humphrey visual field analysis was obtained postoperatively in 18 patients who had undergone SelAH and in 33 patients who had undergone StTL. The SelAH was performed via a transcortical approach through the middle temporal gyrus and included the amygdala, 3 cm of the hippocampus, and the parahippocampal gyrus. The visual field pattern deviation was used for analysis. We considered a defect clinically significant if there were 3 contiguous coordinates affected at the 5% level or 2 at the 1% level. RESULTS: All but 2 of 18 patients who had undergone SelAH had homonymous superior quadrantic visual field defects contralateral to the side of the surgery. One patient had no defects by our criteria, and one had a mild defect that reached significance only in the ipsilateral eye. The averaged defect affected mostly coordinates close to the vertical meridian with relative sparing of points close to the horizontal meridian. All but 3 of the 33 patients who had undergone StTL had homonymous superior quadrantic visual field defects. One patient had no defects; 2 had defects that reached significance in only one eye. The averaged defect involved all points in the affected quadrant, but was also greater near the vertical meridian. Of 13 tested visual field coordinates, 4 were significantly less affected by SelAH in the ipsilateral eye and 3 in the contralateral eye. The coordinates close to the horizontal meridian were significantly spared by SelAH. CONCLUSIONS: Visual field defects are very common after SelAH but are significantly less pronounced than after StTL. In particular, the visual field close to the horizontal meridian is relatively spared in SelAH.


Asunto(s)
Epilepsia del Lóbulo Temporal/cirugía , Procedimientos Neuroquirúrgicos/efectos adversos , Complicaciones Posoperatorias/etiología , Lóbulo Temporal/cirugía , Baja Visión/etiología , Vías Visuales/lesiones , Adolescente , Adulto , Amígdala del Cerebelo/fisiopatología , Amígdala del Cerebelo/cirugía , Niño , Femenino , Hemianopsia/etiología , Hemianopsia/patología , Hemianopsia/fisiopatología , Hipocampo/patología , Hipocampo/fisiopatología , Hipocampo/cirugía , Humanos , Enfermedad Iatrogénica/prevención & control , Masculino , Persona de Mediana Edad , Procedimientos Neuroquirúrgicos/métodos , Complicaciones Posoperatorias/prevención & control , Estudios Retrospectivos , Lóbulo Temporal/patología , Lóbulo Temporal/fisiopatología , Baja Visión/patología , Baja Visión/fisiopatología , Campos Visuales/fisiología , Vías Visuales/patología , Vías Visuales/fisiopatología , Adulto Joven
2.
Clin Nephrol ; 34(5): 223-4, 1990 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-2176580

RESUMEN

Hypophosphatemia complicating parathyroidectomy for secondary hyperparathyroidism in renal failure is usually corrected by the oral or intravenous routes. We present a case in which those methods of treatment were not possible, and the phosphate was administered intraperitoneally. Phosphate was added as one molar sodium diphosphate solution to the dialysis fluid. In our case the procedure was well tolerated, phosphate blood levels were rapidly corrected, no alterations in calcium, magnesium or other parameters were detected and the patient was discharged in good condition. In selected cases of hungry bone syndrome after parathyroidectomy, intraperitoneal phosphate can be used safely.


Asunto(s)
Difosfatos/administración & dosificación , Paratiroidectomía/efectos adversos , Diálisis Peritoneal , Fosfatos/sangre , Adulto , Trastorno Mineral y Óseo Asociado a la Enfermedad Renal Crónica/etiología , Soluciones para Diálisis , Difosfatos/uso terapéutico , Femenino , Humanos , Hiperparatiroidismo Secundario/cirugía , Fallo Renal Crónico/complicaciones
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA